New drug shows promise for hard-to-treat stroke type
NCT ID NCT06037889
First seen Jan 06, 2026 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tested whether a drug called tirofiban, given through a vein, helps people recover better from a specific type of stroke called branch atheromatous disease (BAD). BAD strokes often get worse quickly and have poor outcomes. The trial involved 516 adults aged 18-75 who had a stroke within the last 48 hours. Researchers compared tirofiban plus standard care to standard care alone, measuring how many people could return to normal daily activities (no significant disability) after 90 days. They also checked for serious bleeding risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRANCH ATHEROMATOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Chifeng University
Chifeng, Hebei, 024099, China
-
Beijing Shijitan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Beijing Shunyi Hospital
Beijing, Beijing Municipality, 101300, China
-
Botou City Hospital
Botou, Hebei, China
-
Cangzhou Central Hospital
Cangzhou, Hebei, China
-
Chengde Central Hospital
Chengde, Hebei, 067024, China
-
Deyang People's Hospital
Deyang, Sichuan, 618099, China
-
Hengshui People's Hospital
Hengshui, Hebei, 053099, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Meihekou Central Hospital
Meihekou, Jilin, 135022, China
-
Mianyang Central Hospital
Mianyang, Sichuan, 621099, China
-
North China University of Science and Technology Affiliated Hospital
Tangshan, Hebei, 063000, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Shengli Oilfield Central Hospital
Dongying, Shandong, 257099, China
-
The First Affiliated Hospital of Xinxiang Medical Unversity
Xinxiang, Henan, 453100, China
-
The First Hospital of Tsinghua University
Beijing, Beijing Municipality, China
-
The First People's Hospital of Shangqiu
Shangqiu, Henan, 476005, China
-
The First People's Hospital of Yibin
Yibin, Sichuan, 644000, China
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
-
The Second Hospital of Tianjin Medical University
Tianjing, Tianjing, 300211, China
-
The Second People's Hospital of Yibin
Yibin, Sichuan, 644000, China
-
The second hospital of Baoding
Baoding, Hebei, 071051, China
-
Tibet Autonomous Region People's Hospital
Lhasa, Tibet, 850000, China
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221009, China
-
Yellow River SANMENXIA Hospital
Sanmenxia, Henan, China
Conditions
Explore the condition pages connected to this study.